SummaryPolymyxins are cationic lipopeptide antibiotics active against many species of Gram-negative bacteria. We sequenced the gene cluster for polymyxin biosynthesis from Paenibacillus polymyxa PKB1. The 40.8 kb gene cluster comprises three nonribosomal peptide synthetase-encoding genes and two ABC transporter-like genes. Disruption of a peptide synthetase gene abolished all antibiotic production, whereas deletion of one or both transporter genes only reduced antibiotic production. Computational analysis of the peptide synthetase modules suggested that the enzyme system produces variant forms of polymyxin B (1 and 2), with D-2,4-diaminobutyrate instead of L-2,4-diaminobutyrate in amino acid position 3. Two antibacterial metabolites were re...
Background: Nine gene clusters dedicated to nonribosomal synthesis of secondary metabolites with pos...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...
SummaryPolymyxins are cationic lipopeptide antibiotics active against many species of Gram-negative ...
The increasing prevalence of polymyxin-resistant bacteria has stimulated the search for improved pol...
International audienceColistin is a mixture of polymyxin E1 and E2, bactericidal pentacationic lipop...
AbstractBackground: Myxobacteria have been well established as a potent source for natural products ...
Paenibacilli are efficient producers of potent agents against bacterial and fungal pathogens, which ...
SummaryPaenibacillus polymyxa PKB1 produces fusaricidins, a family of lipopeptide antibiotics that s...
PubMed ID: 17071789A new bacterial strain, displaying potent antimicrobial properties against gram-n...
BACKGROUND:Paenibacillus polymyxa is a bacterium widely used in agriculture, industry, and environme...
La colistine, antibiotique appartenant à la famille des polymyxines, est un polypeptide cyclique, ca...
Colistin is a cationic cyclic polypeptide antibiotic belonging to the polymyxin family and targeting...
Polymyxin E belongs to cationic polypeptide antibiotic bearing four types of direct precursor amino ...
International audiencePolymyxins are polycationic antimicrobial peptides that are currently the last...
Background: Nine gene clusters dedicated to nonribosomal synthesis of secondary metabolites with pos...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...
SummaryPolymyxins are cationic lipopeptide antibiotics active against many species of Gram-negative ...
The increasing prevalence of polymyxin-resistant bacteria has stimulated the search for improved pol...
International audienceColistin is a mixture of polymyxin E1 and E2, bactericidal pentacationic lipop...
AbstractBackground: Myxobacteria have been well established as a potent source for natural products ...
Paenibacilli are efficient producers of potent agents against bacterial and fungal pathogens, which ...
SummaryPaenibacillus polymyxa PKB1 produces fusaricidins, a family of lipopeptide antibiotics that s...
PubMed ID: 17071789A new bacterial strain, displaying potent antimicrobial properties against gram-n...
BACKGROUND:Paenibacillus polymyxa is a bacterium widely used in agriculture, industry, and environme...
La colistine, antibiotique appartenant à la famille des polymyxines, est un polypeptide cyclique, ca...
Colistin is a cationic cyclic polypeptide antibiotic belonging to the polymyxin family and targeting...
Polymyxin E belongs to cationic polypeptide antibiotic bearing four types of direct precursor amino ...
International audiencePolymyxins are polycationic antimicrobial peptides that are currently the last...
Background: Nine gene clusters dedicated to nonribosomal synthesis of secondary metabolites with pos...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...
The emerging threat of infections caused by highly drug-resistant bacteria has prompted a resurgence...